Agile Therapeutics, Inc. Accrued Bonuses, Current
Agile Therapeutics, Inc. had Accrued Bonuses, Current of $664.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-04.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2021-05-04
- 2021-03-31: Accrued Bonuses, Current $664.00K.
- 2020-12-31: Accrued Bonuses, Current $1.70M.
- 2020-09-30: Accrued Bonuses, Current $1.17M.
- 2020-06-30: Accrued Bonuses, Current $674.00K.
| Period end | Accrued Bonuses, Current | Accrued Bonuses, Current as first filed |
|---|---|---|
| 2021-03-31 | $664.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.70M 10-Q · filed 2021-05-04 | |
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $674.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $325.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.44M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $638.00K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $540.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $275.00K 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $621.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $820.00K 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $549.00K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $375.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $215.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $946.00K 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $631.00K 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $346.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.04M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $740.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $485.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $245.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $938.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $640.11K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $422.59K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $211.30K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $665.00K 10-K · filed 2016-03-09 | $665.05K 10-K · filed 2015-03-26 |
| 2014-09-30 | $435.48K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $254.13K 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $238.94K 10-K · filed 2015-03-26 |